The myostatin gene: physiology and pharmacological relevance

D Joulia-Ekaza, G Cabello - Current opinion in pharmacology, 2007 - Elsevier
… the activin receptor ActRIIB and Smads 2 and 3. Approaches … -deficient mouse model of
limb-girdle muscular dystrophy 1C… model, does not improve all aspects of muscle pathology; this …

Myostatin in the pathophysiology of skeletal muscle

A Bonnieu, G Carnac, B Vernus - Current genomics, 2007 - ingentaconnect.com
mouse model of Duchenne muscular dystrophy, in the caveolin 3 deficient model of limb-girdle
muscular … the muscle pathology but increased postnatal lethality [41]. With respect to the …

[HTML][HTML] ERK1/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity

JG Boyer, V Prasad, T Song, D Lee, X Fu, KM Grimes… - JCI insight, 2019 - ncbi.nlm.nih.gov
… in a mouse model of limb-girdle muscle dystrophy and protected … myostatin/SMAD2 signaling
(22). Conversely, the loss of JNK1/… the histopathology in Sgcd –/– mice and improved their …

[HTML][HTML] Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice

J Dumonceaux, S Marie, C Beley, C Trollet, A Vignaud… - Molecular Therapy, 2010 - cell.com
… Duchenne muscular dystrophy is characterized by muscular atrophy, … inhibition in the dystrophic
mdx mouse model. … AAV-treated muscles and PBS-injected muscles (Figure 2): centrally …

Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice

ER Wissing, DP Millay, G Vuagniaux… - Neuromuscular …, 2010 - Elsevier
muscular dystrophy in the mdx mouse model of disease. … cis–trans isomerase that facilitates
pore formation due to Ca 2+ … role for Debio-025 in the treatment of Duchenne, limb-girdle, …

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors

GC Minetti, C Colussi, R Adami, C Serra, C Mozzetta… - Nature medicine, 2006 - nature.com
… mice—a model of limb girdle muscular dystrophy (LGMD) 11 … Myostatin blockade at
early stages of the disease provides a … therapy of mouse models of muscular dystrophy is of …

[HTML][HTML] Caveolin-3 regulates myostatin signaling. Mini-review

Y Ohsawa, T Okada, A Kuga, S Hayashi… - Acta …, 2008 - ncbi.nlm.nih.gov
… In addition, a mouse model of LGMD1C has shown atrophic … in autosomal dominant limb-girdle
muscular dystrophy (LGMD) 1C … myostatin prodomain has ameliorates the pathology of …

[图书][B] Pathogenic pathways and preclincial testing in mouse models of muscular dystrophy

BB Gardner - 2016 - search.proquest.com
… and implications of blocking TGF[beta] in Muscular Dystrophy….… data alongside
histopathological quantitation, I found … a mouse model of Limb Girdle Muscular Dystrophy type 2, …

[HTML][HTML] Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis

J Zhu, Y Li, A Lu, B Gharaibeh, J Ma… - … journal of pathology, 2011 - Elsevier
… also inhibits myofiber regeneration in mouse models thatdystrophy, and limb-girdle muscular
dystrophy. The results of … have shown that that follistatin inhibits not only myostatin but also …

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials

G Cossu, M Sampaolesi - Trends in molecular medicine, 2007 - cell.com
… trial for limb girdle muscular dystrophy 2C – by intramuscular injection in the radial muscle of
γ… of the human counterparts of mouse mesoangioblasts from adult skeletal muscle revealed …